Your browser doesn't support javascript.
loading
A circulating subset of iNKT cells mediates antitumor and antiviral immunity.
Cui, Guangwei; Shimba, Akihiro; Jin, Jianshi; Ogawa, Taisaku; Muramoto, Yukiko; Miyachi, Hitoshi; Abe, Shinya; Asahi, Takuma; Tani-Ichi, Shizue; Dijkstra, Johannes M; Iwamoto, Yayoi; Kryukov, Kirill; Zhu, Yuanbo; Takami, Daichi; Hara, Takahiro; Kitano, Satsuki; Xu, Yan; Morita, Hajime; Zhang, Moyu; Zreka, Lynn; Miyata, Keishi; Kanaya, Takashi; Okumura, Shinya; Ito, Takashi; Hatano, Etsuro; Takahashi, Yoshimasa; Watarai, Hiroshi; Oike, Yuichi; Imanishi, Tadashi; Ohno, Hiroshi; Ohteki, Toshiaki; Minato, Nagahiro; Kubo, Masato; Holländer, Georg A; Ueno, Hideki; Noda, Takeshi; Shiroguchi, Katsuyuki; Ikuta, Koichi.
Affiliation
  • Cui G; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Shimba A; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Jin J; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ogawa T; Laboratory for Prediction of Cell Systems Dynamics, RIKEN Center for Biosystems Dynamics Research (BDR) , Osaka, Japan.
  • Muramoto Y; Laboratory for Prediction of Cell Systems Dynamics, RIKEN Center for Biosystems Dynamics Research (BDR) , Osaka, Japan.
  • Miyachi H; Laboratory of Ultrastructural Virology, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Abe S; Reproductive Engineering Team, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Asahi T; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Tani-Ichi S; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Dijkstra JM; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Iwamoto Y; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Kryukov K; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Zhu Y; Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan.
  • Takami D; Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hara T; Biomedical Informatics Laboratory, Department of Molecular Life Science, Tokai University, Kanagawa, Japan.
  • Kitano S; Biological Networks Laboratory, Department of Informatics, National Institute of Genetics, Shizuoka, Japan.
  • Xu Y; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Morita H; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Zhang M; Graduate School of Pharmaceutical Science, Kyoto University, Kyoto, Japan.
  • Zreka L; Laboratory of Immune Regulation, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Miyata K; Reproductive Engineering Team, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Kanaya T; Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Okumura S; Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ito T; Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hatano E; Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Takahashi Y; Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Watarai H; Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
  • Oike Y; Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Imanishi T; Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ohno H; Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ohteki T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
  • Minato N; Department of Immunology and Stem Cell Biology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan.
  • Kubo M; Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Holländer GA; Biomedical Informatics Laboratory, Department of Molecular Life Science, Tokai University, Kanagawa, Japan.
  • Ueno H; Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
  • Noda T; Department of Biodefense Research, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
  • Shiroguchi K; Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ikuta K; Laboratory for Cytokine Regulation, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Sci Immunol ; 7(76): eabj8760, 2022 10 28.
Article in En | MEDLINE | ID: mdl-36269840
ABSTRACT
Invariant natural killer T (iNKT) cells are a group of innate-like T lymphocytes that recognize lipid antigens. They are supposed to be tissue resident and important for systemic and local immune regulation. To investigate the heterogeneity of iNKT cells, we recharacterized iNKT cells in the thymus and peripheral tissues. iNKT cells in the thymus were divided into three subpopulations by the expression of the natural killer cell receptor CD244 and the chemokine receptor CXCR6 and designated as C0 (CD244-CXCR6-), C1 (CD244-CXCR6+), or C2 (CD244+CXCR6+) iNKT cells. The development and maturation of C2 iNKT cells from C0 iNKT cells strictly depended on IL-15 produced by thymic epithelial cells. C2 iNKT cells expressed high levels of IFN-γ and granzymes and exhibited more NK cell-like features, whereas C1 iNKT cells showed more T cell-like characteristics. C2 iNKT cells were influenced by the microbiome and aging and suppressed the expression of the autoimmune regulator AIRE in the thymus. In peripheral tissues, C2 iNKT cells were circulating that were distinct from conventional tissue-resident C1 iNKT cells. Functionally, C2 iNKT cells protected mice from the tumor metastasis of melanoma cells by enhancing antitumor immunity and promoted antiviral immune responses against influenza virus infection. Furthermore, we identified human CD244+CXCR6+ iNKT cells with high cytotoxic properties as a counterpart of mouse C2 iNKT cells. Thus, this study reveals a circulating subset of iNKT cells with NK cell-like properties distinct from conventional tissue-resident iNKT cells.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Natural Killer T-Cells Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Natural Killer T-Cells Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article